This New $7 Million Bet Targets a CNS Drug Maker With Phase 3 Trial Underway and 27% Stock Gain.
Share this article
Corporate
Score 45
Bullish
This New $7 Million Bet Targets a CNS Drug Maker With Phase 3 Trial Underway and 27% Stock Gain
Mar 18, 2026 15:57 UTC
CL=F, ^VIX
Short term
Related Articles
Score 85
Bearish
Oil Prices Drop as U.S. Considers Lifting Sanctions on Iranian Crude
Mar 20, 00:52
Score 45
Bullish
OpenAI to create desktop super app, combining ChatGPT app, browser and Codex app
Mar 20, 00:29
Score 85
Bearish
Asia markets track losses on Wall Street, extending market rout on Iran war impact
Mar 20, 00:29
Score 85
Takaichi and Trump Confront Iran War Tensions Amid Alliances Under Pressure
Mar 20, 00:25
Stay Ahead of the Markets
Join thousands of traders using AI-powered market intelligence. Get personalized insights, real-time alerts, and advanced analysis tools.